Guido Rovera

8PUBLICATIONS
98CO-AUTHORS
Medical mycologyGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Veterinary epidemiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 24, 2026
Omitting Bone Marrow Sampling in FDG-Avid Rhabdomyosarcoma With 2-[18F]FDG PET-Negative Marrow: Results From an International Retrospective Study.

|Jul 28, 2026
PET/CT Imaging for Therapy Assessment in Multiple Myeloma Including MRD.

|Feb 25, 2026
PSMA-PET imaging in prostate cancer patients with high-risk biochemical recurrence: implications from an "EMBARK-Like" cohort.

Matteo Droghetti, Valerio Pirelli, Francesco Ceci

|Oct 16, 2025
The Value of Baseline [18F]FDG-PET in Predicting the Progression-Free Survival in Patients with Thymic Epithelial Tumours: A Systematic Review and Meta-Analysis.

Alberto Miceli, Maria Librando, Francesco Dondi

|Oct 22, 2024
Metabolic Tumor Volume Assessed by 18F FDG-PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates.

Filippo G Dall'Olio, Wael Zrafi, Veronique Roelants

|Sep 28, 2023
Machine Learning CT-Based Automatic Nodal Segmentation and PET Semi-Quantification of Intraoperative 68Ga-PSMA-11 PET/CT Images in High-Risk Prostate Cancer: A Pilot Study.

Guido Rovera, Serena Grimaldi, Marco Oderda

Pageof 2

Frequent Collaborators

3 joint publications

Désirée Deandreis

2 joint publications

Roberto Passera

2 joint publications

Francesco Lanfranchi

2 joint publications

Matteo Bauckneht